During the past decade, Konkuk University Medical Center conducted 140 clinical trials. In the 10-year time frame, 140 clinical trials started and 56 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 39 clinical trials were completed. i.e. 88.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Konkuk University Medical Center" #1 sponsor was "Konkuk University Medical Center" with 51 trials, followed by "Pfizer" with 15 trials sponsored, "Hoffmann-La Roche" with 12 trials sponsored, "Eli Lilly and Company" with 10 trials sponsored and "Janssen Research & Development, LLC" with 10 trials sponsored. Other sponsors include 103 different institutions and companies that sponsored additional 81 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Konkuk University Medical Center" #1 collaborator was "Severance Hospital" with 7 trials as a collaborator, "Samsung Medical Center" with 6 trials as a collaborator, "Seoul National University Hospital" with 6 trials as a collaborator, "Chung-Ang University Hosptial, Chung-Ang University College of Medicine" with 5 trials as a collaborator and "Seoul St. Mary's Hospital" with 5 trials as a collaborator. Other collaborators include 128 different institutions and companies that were collaborators in the rest 90 trials.

According to Clinical.Site data, the most researched conditions in "Konkuk University Medical Center" are "Alzheimer's Disease" (15 trials), "Rheumatoid Arthritis" (10 trials), "Atopic Dermatitis" (7 trials), "Breast Cancer" (5 trials) and "Valvular Heart Disease" (5 trials). Many other conditions were trialed in "Konkuk University Medical Center" in a lesser frequency.

Most popular intervention types in "Konkuk University Medical Center" are "Drug" (148 trials), "Procedure" (14 trials), "Other" (13 trials), "Biological" (12 trials) and "Device" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (54 trials), "Gantenerumab" (5 trials), "Baricitinib" (4 trials), "Crenezumab" (3 trials) and "Donepezil" (3 trials). Other intervention names were less common.

The vast majority of trials in "Konkuk University Medical Center" are 192 trials for "All" genders and 13 trials for "Female" genders.

Currently, there are NaN active trials in "Konkuk University Medical Center". undefined are not yet recruiting, 24 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 130 completed trials in Konkuk University Medical Center, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Konkuk University Medical Center, 2 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 31 trials, and there were also 26 trials that are defined as “Not Applicable".

Konkuk University Medical Center has several departments that took part in Clinical trials: "Healthcare Center, Digestive Disease Center, Konkuk University Medical Center" - 2 trials, "Konkuk University Medical Center, Department of Neurology" - 2 trials